StonvexLoading…
StonvexStonvexStonvexReal-time TradingView chart with full indicator set.
Last 7 days, powered by Finnhub. Tap Analyze to classify direction.
Loading latest news…
Pick the depth your tier unlocks. Logged-in Pro/Premium users automatically get the deeper report.
Free preview · 3 reports / hour · No sign-up required
Factor grades, AI Copilot, personalized ranking, and deeper event analysis.
Upgrade to Pro →6-factor scoring with sector-relative rank. Updated daily.
Each row shows where BDX sits in our scored universe today on a single observational measurement. P85 means BDX ranks above 85% of peers on that factor right now. Percentile rankings are descriptive — they are not buy/sell signals or quality judgments. Universe refreshed every 60 seconds.
Today's volume vs prior session average.
Absolute daily price move vs peers.
24h article count relative to the universe.
AI-classified polarity of recent news.
Today's dollar turnover (volume × VWAP).
Signed daily return vs the rest of the universe.
Stonvex publishes percentile measurements as observational data only. Nothing here constitutes a recommendation, prediction, or advice about whether to buy, sell, or hold any security. Stonvex is not a registered investment advisor.
Share this analysis with other traders
Disclaimer: The content on this page is for informational and educational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Past performance does not guarantee future results. Consult a licensed financial advisor before making any investment decisions.
Aggregate of 21 sell-side ratings as of 2026-05-01. Stonvex does not endorse these ratings.
Indicator values from Polygon. Educational only — single- indicator triggers in isolation are not a complete trading signal.
Earnings (▲ beat / ▼ miss) and ex-dividend dates plotted on the price line. Educational — proximity does not establish causation.
Next report date, year-over-year trend, and recent quarter history.
Aggregated from Polygon's per-article sentiment classifications. Educational — sentiment is descriptive, not predictive.
| Date | Open | Close | Δ | Vol |
|---|---|---|---|---|
| 05-22 | $146.68 | $147.63 | +0.65% | 1.3M |
| 05-26 | $147.63 | $147.75 | +0.08% | 3.2M |
| 05-27 | $147.60 | $147.24 | -0.24% | 2.9M |
| 05-28 | $146.20 | $148.41 | +1.51% | 3.2M |
| 05-29 | $148.26 | $147.12 | -0.77% | 3.7M |
Past 1 reported quarters: EPS surprise vs estimate and the day-after-release stock reaction. Past performance does not predict future moves.
Sources: Finnhub earnings calendar + Polygon daily aggregates. Reaction direction can diverge from EPS surprise (guidance, macro, or sector flow can dominate the next-day print).
Documents are served directly from sec.gov / the issuer's website — Stonvex does not proxy or store filings.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q3 2026 (Est.) Expected 2026-08-05 | Q1 2026 2026-03-31 | Q4 2025 2025-12-31 | Annual 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|---|
Revenue | $4.93B | $9.20B | $5.25B | $21.84B | $15.95B |
Operating Income | Not available | $562.00M | $552.00M | $2.58B | $1.88B |
Net Income | Not available | $72.00M | $382.00M | $1.68B | $1.19B |
EPS (Diluted) | $3.16 | $0.25 | $1.34 | $5.82 | $4.10 |
Total Assets | Not available | $50.83B | $54.84B | $55.33B | $54.90B |
Total Liabilities | Not available | Not available | Not available | Not available | Not available |
Cash & Equivalents | Not available | $813.00M | $740.00M | $567.00M | $735.00M |
Free Cash Flow OCF − CapEx | Not available | $1.09B | $549.00M | $2.67B | $1.67B |
Shares Outstanding | Not available | 284.63M | 285.85M | 288.51M | 288.69M |
No sell-side coverage available for BDX yet.
Common for small-cap names, ETFs, recent IPOs, and ADRs without US-listed sell-side coverage. When analysts publish, ratings appear here within one business day.
5-factor analysis: Valuation, Growth, Profitability, Momentum, Financial Health.
Each factor shows BDX's percentile within the scored universe — observational ranking, not a recommendation.
What drives BDX's price movement
Follow the money. Institutional flows and fund positioning are key drivers.
Mixed retail/institutional activity
Moderate volume-sensitivity
Moderate news sensitivity
Moderate sentiment influence
Underperforming peers — laggard in sector
Not momentum-driven — mean-reverts quickly
DNA analysis is based on current factor scoring. Not investment advice.
Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.